CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Home New Certificate of Suitability (CEP) of Tiapride hydrochloride
News
22 Jul 2019

New Certificate of Suitability (CEP) of Tiapride hydrochloride

LEBSA recently got the Certificate of Suitability (CEP) -R0-CEP 2018-066-Rev 00- by EDQM of Tiapride hydrochloride (CAS 51012-33-0) to offer the best quality product to our customers at the most affordable price.

Tiapride hydrochloride (CAS 51012-33-0)  is an antipsychotic agent manufactured in our unique GMP plant located in Barcelona, Spain.

Contact us for more information
Mentioned Companies
Lebsa
View company profile
Related categories
API Contract Manufacturing Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) Exclusive Synthesis of APIs Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)